Vaxcyte, Inc.

NasdaqGS:PCVX Stok Raporu

Piyasa değeri: US$13.8b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Vaxcyte Yönetim

Yönetim kriter kontrolleri 4/4

Vaxcyte's CEO'su Grant Pickering, Nov2013 tarihinde atandı, in görev süresi 10.92 yıldır. in toplam yıllık tazminatı $ 12.14M olup, şirket hissesi ve opsiyonları dahil olmak üzere 5.3% maaş ve 94.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.54% ine doğrudan sahiptir ve bu hisseler $ 76.65M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.4 yıl ve 5.5 yıldır.

Anahtar bilgiler

Grant Pickering

İcra Kurulu Başkanı

US$12.1m

Toplam tazminat

CEO maaş yüzdesi5.3%
CEO görev süresi10.9yrs
CEO sahipliği0.5%
Yönetim ortalama görev süresi4.4yrs
Yönetim Kurulu ortalama görev süresi5.5yrs

Son yönetim güncellemeleri

Recent updates

Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy

Sep 06

We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Aug 24
We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

May 10
Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Dec 27
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Sep 12
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

May 30
Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Dec 22
We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Vaxcyte appoints new CBO, CMO

Oct 11

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Aug 05
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Vaxcyte completes enrollment in phase 2 portion of study of pneumonia vaccine candidate

Jul 12

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Feb 25
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

CEO Tazminat Analizi

Grant Pickering'un ücretlendirmesi Vaxcyte'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$497m

Mar 31 2024n/an/a

-US$437m

Dec 31 2023US$12mUS$640k

-US$402m

Sep 30 2023n/an/a

-US$300m

Jun 30 2023n/an/a

-US$265m

Mar 31 2023n/an/a

-US$245m

Dec 31 2022US$14mUS$601k

-US$223m

Sep 30 2022n/an/a

-US$174m

Jun 30 2022n/an/a

-US$143m

Mar 31 2022n/an/a

-US$118m

Dec 31 2021US$5mUS$575k

-US$100m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$87m

Mar 31 2021n/an/a

-US$83m

Dec 31 2020US$3mUS$481k

-US$89m

Sep 30 2020n/an/a

-US$83m

Jun 30 2020n/an/a

-US$73m

Mar 31 2020n/an/a

-US$64m

Dec 31 2019US$596kUS$426k

-US$50m

Tazminat ve Piyasa: Grant 'ın toplam tazminatı ($USD 12.14M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 13.04M ).

Tazminat ve Kazançlar: Grant 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Grant Pickering (56 yo)

10.9yrs

Görev süresi

US$12,135,683

Tazminat

Mr. Grant E. Pickering, M.B.A., is Co-Founder of Vaxcyte, Inc. since 2013 and has been its Chief Executive Officer and Director since November 2013 and served as its President since November 2013 until Dec...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Grant Pickering
Co-Founder10.9yrsUS$12.14m0.54%
$ 74.7m
Andrew Guggenhime
President & CFO4.4yrsUS$5.42m0.044%
$ 6.1m
James Wassil
Executive VP & COO4.8yrsUS$5.40m0.14%
$ 18.7m
Mikhail Eydelman
Senior VP2.5yrsUS$3.49m0.0082%
$ 1.1m
Ashish Khanna
Co-Founder11.8yrsVeri yokVeri yok
Jeff Fairman
Co-Founder & VP of Researchno dataVeri yokVeri yok
Elvia Cowan
Senior VP of Finance & Principal Accounting Officer1.8yrsVeri yok0.0032%
$ 435.0k
Janet Graesser
Senior Vice President of Corporate Communications & Investor Relationsno dataVeri yokVeri yok
Whitney Jones
Chief People Officerless than a yearVeri yokVeri yok
Paul Sauer
Senior Vice President of Process Development & Manufacturing8.5yrsUS$2.35mVeri yok
Harp Dhaliwal
Senior Vice President of Commercial Manufacturing & Supply Chain2.9yrsUS$1.84mVeri yok
Sam Iki
Senior Vice President of Project Managementno dataVeri yokVeri yok

4.4yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: PCVX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.4 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Grant Pickering
Co-Founder10.9yrsUS$12.14m0.54%
$ 74.7m
Thomas Monath
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Annie Drapeau
Independent Director3.1yrsUS$704.22k0.0046%
$ 626.4k
K. Hirth
Independent Director8.1yrsUS$696.72k0.010%
$ 1.4m
Heath Lukatch
Independent Director6.4yrsUS$691.72k0.0046%
$ 626.4k
Halley Gilbert
Independent Director4.5yrsUS$704.22k0.0046%
$ 626.4k
Emmanuel Walter
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Carlos Paya
Independent Chairman of the Board3yrsUS$724.22k0.0046%
$ 626.4k
Anthony Ford-Hutchinson
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Jeffrey Almond
Member of Scientific Advisory Board7.8yrsVeri yokVeri yok
Teri Loxam
Independent Director3.1yrsUS$704.22k0.0046%
$ 626.4k
William Hausdorff
Member of Scientific Advisory Boardno dataVeri yokVeri yok

5.5yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PCVX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.5 yıldır).